Affordable Access

Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation.

Authors
  • Kang, Yeon-Joo
  • Mbonye, Uri R
  • DeLong, Cynthia J
  • Wada, Masayuki
  • Smith, William L
Type
Published Article
Journal
Progress in lipid research
Publication Date
Mar 01, 2007
Volume
46
Issue
2
Pages
108–125
Identifiers
PMID: 17316818
Source
Medline
License
Unknown

Abstract

Cyclooxygenases-1 and -2 (COX-1 and -2) catalyze the committed step in prostaglandin formation. Each isozyme subserves different biological functions. This is, at least in part, a consequence of differences in patterns of COX-1 and COX-2 expression. COX-1 is induced during development, and COX-1 mRNA and COX-1 protein are very stable. These latter properties can explain why COX-1 protein levels usually remain constant in those cells that express this isozyme. COX-2 is usually expressed inducibly in association with cell replication or differentiation. Both COX-2 mRNA and COX-2 protein have short half-lives relative to those of COX-1. Therefore, COX-2 protein is typically present for only a few hours after its synthesis. Here we review and develop the concepts that (a) COX-2 gene transcription can involve at least six different cis-acting promoter elements interacting with trans-acting factors generated by multiple, different signaling pathways, (b) the relative contribution of each cis-acting COX-2 promoter element depends on the cell type, the stimulus and the time following the stimulus and (c) a unique 27 amino acid instability element located just upstream of the C-terminus of COX-2 targets this isoform to the ER-associated degradation system and proteolysis by the cytosolic 26S proteasome.

Report this publication

Statistics

Seen <100 times